跳至主要内容
临床试验/CTRI/2020/11/029094
CTRI/2020/11/029094尚未招募未知

Comparative study between single dose Rituximab therapy versus multiple dose regimen in idiopathic membranous nephropathy and its correlation with peripheral blood CD19 count

RS Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. biopsy proven membranous nephropathy
  • 2. serologically anti PLA2R antibody positive
  • 3. patients eligible for treatment as per standard protocol
  • 4. patients who are willing to give consent

排除标准

  • 1. presence of active sepsis
  • 2. pregnancy
  • 3. active malignancy
  • 4. co-infection with HIV / Hep B / Hep C
  • 5. prior treatment with any immunosuppressant therapy
  • 6. presence of heart failure

研究者

发起方
RS Medical College and Hospital

相似试验